Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind. But HIVs ability to mutate isnt unique among RNA viruses most viruses develop mutations, or changes in their genetic code, over time. If a virus is disease-causing, the right mutation can allow the virus to escape the immune response by changing the viral pieces the immune system uses to recognize the virus as a threat, pieces scientists call epitopes.
To combat HIVs high rate of mutation, Gaiha and Elizabeth Rossin, MD, PhD, a Retina Fellow at Massachusetts Eye and Ear, a member of Mass General Brigham, developed an approach known as structure-based network analysis. With this, they can identify viral pieces that are constrained, or restricted, from mutation. Changes in mutationally constrained epitopes are rare, as they can cause the virus to lose its ability to infect and replicate, essentially rendering it unable to propagate itself.
When the pandemic began, Gaiha immediately recognized an opportunity to apply the principles of HIV structure-based network analysis to SARS-CoV-2, the virus that causes COVID-19. He and his team reasoned that the virus would likely mutate, potentially in ways that would allow it to escape both natural and vaccine-induced immunity. Using this approach, the team identified mutationally constrained SARS-CoV-2 epitopes that can be recognized by immune cells known as T cells. These epitopes could then be used in a vaccine to train T cells, providing protective immunity. Recently published inCell, this work highlights the possibility of a T cell vaccine which could offer broad protection against new and emerging variants of SARS-CoV-2 and other SARS-like coronaviruses.
From the earliest stages of the COVID-19 pandemic, the team knew it was imperative to prepare against potential future mutations. Other labs already had published the protein structures (blueprints) of roughly 40% of the SARS-CoV-2 virus, and studies indicated that patients with a robust T cell response, specifically a CD8+ T cell response, were more likely to survive COVID-19 infection.
Gaihas team knew these insights could be combined with their unique approach: the network analysis platform to identify mutationally constrained epitopes and an assay they had just developed, a report on which is currently in press atCell Reports, to identify epitopes that were successfully targeted by CD8+ T cells in HIV-infected individuals. Applying these advances to the SARS-CoV-2 virus, they identified 311 highly networked epitopes in SARS-CoV-2 likely to be both mutationally constrained and recognized by CD8+ T cells.
These highly networked viral epitopes are connected to many other viral parts, which likely provides a form of stability to the virus, says Anusha Nathan, a medical student in the Harvard-MIT Health Sciences and Technology program and cofirst author of the study. Therefore, the virus is unlikely to tolerate any structural changes in these highly networked areas, making them resistant to mutations.
You can think of a viruss structure like the design of a house, explains Nathan. The stability of a house depends on a few vital elements, like support beams and a foundation, which connect to and support the rest of the houses structure. It is therefore possible to change the shape or size of features like doors and windows without endangering the house itself. Changes to structural elements, like support beams, however, are far riskier. In biological terms, these support beams would be mutationally constrained any significant changes to size or shape would risk the structural integrity of the house and could easily lead to its collapse.
Highly networked epitopes in a virus function as support beams, connecting to many other parts of the virus. Mutations in such epitopes can risk the viruss ability to infect, replicate, and ultimately survive. These highly networked epitopes, therefore, are often identical, or nearly identical, across different viral variants and even across closely related viruses in the same family, making them an ideal vaccine target.
The team studied the identified 311 epitopes to find which were both present in large amounts and likely to be recognized by the vast majority of human immune systems. They ended up with 53 epitopes, each of which represents a potential target for a broadly protective T cell vaccine. Since patients who have recovered from COVID-19 infection have a T cell response, the team was able to verify their work by seeing if their epitopes were the same as ones that had provoked a T cell response in patients who had recovered from COVID-19. Half of the recovered COVID-19 patients studied had T cell responses to highly networked epitopes identified by the research team. This confirmed that the epitopes identified were capable of inducing an immune reaction, making them promising candidates for use in vaccines.
A T cell vaccine that effectively targets these highly networked epitopes, says Rossin, who is also a cofirst author of the study, would potentially be able to provide long-lasting protection against multiple variants of SARS-CoV-2, including future variants.
By this time, it was February 2021, more than a year into the pandemic, and new variants of concern were showing up across the globe. If the teams predictions about SARS-CoV-2 were correct, these variants of concerns should have had little to no mutations in the highly networked epitopes they had identified.
The team obtained sequences from the newly circulating B.1.1.7 Alpha, B.1.351 Beta, P1 Gamma, and B.1.617.2 Delta SARS-CoV-2 variants of concern. They compared these sequences with the original SARS-CoV-2 genome, cross-checking the genetic changes against their highly networked epitopes. Remarkably, of all the mutations they identified, only three mutations were found to affect highly networked epitopes sequences, and none of the changes affected the ability of these epitopes to interact with the immune system.
Initially, it was all prediction, says Gaiha, an investigator in the MGH Division of Gastroenterology and senior author of the study. But when we compared our network scores with sequences from the variants of concern and the composite of circulating variants, it was like nature was confirming our predictions.
In the same time period, mRNA vaccines were being deployed and immune responses to those vaccines were being studied. While the vaccines induce a strong and effective antibody response, Gaihas group determined they had a much smaller T cell response against highly networked epitopes compared to patients who had recovered from COVID-19 infections.
While the current vaccines provide strong protection against COVID-19, Gaiha explains, its unclear if they will continue to provide equally strong protection as more and more variants of concern begin to circulate. This study, however, shows that it may be possible to develop a broadly protective T cell vaccine that can protect against the variants of concern, such as the Delta variant, and potentially even extend protection to future SARS-CoV-2 variants and similar coronaviruses that may emerge.
Reference: Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses by Anusha Nathan, Elizabeth J. Rossin, Clarety Kaseke, Ryan J. Park, Ashok Khatri, Dylan Koundakjian, Jonathan M. Urbach, Nishant K. Singh, Arman Bashirova, Rhoda Tano-Menka, Fernando Senjobe, Michael T. Waring, Alicja Piechocka-Trocha,Wilfredo F. Garcia-Beltran, A. John Iafrate, Vivek Naranbhai, Mary Carrington, Bruce D. Walker, Gaurav D. Gaiha, Accepted, Cell.DOI: 10.1016/j.cell.2021.06.029
Gaiha is an assistant professor of Medicine at Harvard Medical School. Additional authors include Clarety Kaseke, Ryan J. Park, Dylan Koundakjian, Jonathan M. Urbach, PhD, Nishant K. Singh, PhD, Rhoda Tano-Menka, Fernando Senjobe, Michael T. Waring, Alicja Piechocka-Trocha, PhD, Wilfredo F. Garcia-Beltran, MD, and Bruce D. Walker, MD, from the Ragon Institute; A. John Iafrate, MD, Vivek Naranbhai and Ashok Khatri from MGH; Mary Carrington, PhD, of NIH; and Arman Bashirova, NCI.
This study was supported by the National Institutes of Health and the Massachusetts Consortium of Pathogen Readiness (MassCPR). Additional support was provided by the Howard Hughes Medical Institute, the Ragon Institute, the Mark and Lisa Schwartz Foundation and Enid Schwartz (B.D.W.), and Sandy and Paul Edgerly. Roider is supported by the Heed Ophthalmic Foundation. Gaiha is supported by the Bill and Melinda Gates Foundation, a Burroughs Wellcome Career Award for Medical Scientists and the Gilead HIV Research Scholars Program. This project has been funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research.
Conflicts of interest: Roider and Gaiha have filed patent application PCT/US2021/028245.
Read more from the original source:
Potential Path Discovered to a Broadly Protective COVID-19 Vaccine Using T Cells - SciTechDaily
- Covid-19 diagnostic based on MIT technology might be tested on patient samples soon - The MIT Tech [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Dutch researchers first to find Covid-19 antibodies: Report - NL Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Getting Viral: Why COVID-19 is Such a Threat to the 60+ Plus Population and Why the Response May Make It Worse - CounterPunch [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- U.K. Scientists Paying People $4,000 to Get Infected with Coronaviruses - Newsweek [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Youre Likely to Get the Coronavirus - The Atlantic [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Mountain West Scientists Contributing To The Race For A COVID-19 Vaccine - KUNC [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- China Threatens to Withhold COVID-19 Vaccine - The - The Floridian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Look for novel coronavirus treatments first, experts say, and vaccines are further off than you think - FiercePharma [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- COVID-19 vaccine will take at least two years to develop: health officials - The Hindu [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- 'Where's the money?' Inside GeoVax, one lab working to create a COVID-19 vaccine - wgxa.tv [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Homeland Security News Wire: COVID-19 Virus Isolated Better Testing, Treatments, Vaccines Are Near - Los Alamos Daily Post [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- With the coronavirus, drug that once raised global hopes gets another shot - STAT [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Farmington biotech teams with Yale to pursue COVID-19 vaccine - Hartford Business [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Father and daughter virologists working on vaccine for COVID-19 - National Observer [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Sanofi exploring possibility of COVID-19 vaccine that would be produced in Pa. - Bucks County Courier Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- EMA offers free advice to COVID-19 vaccine and therapeutic developers - European Pharmaceutical Review [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Italy COVID-19 total tops 10000; funding grows for treatments, vaccines - CIDRAP [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Free Tests, Free Vaccines: Remove the Wealth Barriers to Fighting COVID-19 - The Nation [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Inovio Pharm gets $5M from Gates Foundation to further COVID-19 vaccine project - The San Diego Union-Tribune [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- On the hunt for a Covid-19 vaccine - Vantage [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- When will a coronavirus vaccine be ready? - The Guardian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus vaccine: why will it take so long to create? - Los Angeles Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Covid-19 vaccine in development by J&J and BIDMC. - Pharmaceutical Technology [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- First COVID-19 vaccine trial starts Monday in Seattle, government official says - KOMO News [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Others at Kansas home tied to COVID-19 death tested negative - hays Post [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Commentary: Is the UK's herd immunity strategy to combat COVID-19 worth pursuing? - CNA [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 5 Promising Covid-19 Vaccines and Drugs That Could End Coronavirus Pandemic - Observer [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First human trial of COVID-19 vaccine gets under way in the US - EWN [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Government official: First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine - Associated Press [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First stage of COVID-19 vaccine testing gets under way - The Mercury News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The Race Is On To Find A Vaccine For COVID-19 - WCCO | CBS Minnesota [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 10 Positive Updates on the COVID-19 Outbreaks From Around the World - Good News Network [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Authorities warn of scam callers seeking sensitive information to reserve a vaccine for COVID-19 - FOX 13 Tampa Bay [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Still on Phase 1 and Might Take 18 Months From Now to Create Says Global Health Official - Tech Times [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Army command continues work on COVID-19 vaccine, treatment | Hospital near Fort Detrick to setup drive-through testing site - WUSA9.com [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Australian researchers have made an important discovery in the race to find a COVID-19 vaccine - SBS News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer - CNBC [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Covid-19 outbreak: the key to quicker vaccine development - Pharmaceutical Technology [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Test Begins With U.S. Volunteer | Time [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The FDA Regulatory Landscape for Covid-19 Treatments and Vaccines - JD Supra [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Montgomery Co. life science companies work together on COVID-19 vaccine - WDVM 25 [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Meet the volunteers testing the new experimental COVID-19 vaccine - CTV News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- The U.S. Should Make COVID-19 Testing, Prevention And Care Free To All - WBUR [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Biotech That Doubled on Covid-19 Frenzy Readies New Flu Vaccine - Bloomberg [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Jones sponsors bill for insurance plans to cover COVID-19 vaccines when they're available - alreporter.com [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Seattle volunteers receive world's first experimental COVID-19 vaccine - KOMO News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- What scientists are working on to find a cure for coronavirus COVID-19 - ABC News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- This study shows how difficult it will be to find Covid-19 vaccine volunteers - Ladders [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Differences between COVID-19 and flu? We have no immunity or vaccine for the new virus, local expert says - WFTV Orlando [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- GeekWire Podcast: Bill Gates on COVID-19, gig workers in peril, and more on the coronavirus crisis - GeekWire [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus vaccine: Expert warns that a usable Covid-19 vaccination won't be available for at least a year - inews [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Is Deadlier Than The Flu. How Else Do They Differ? : Goats and Soda - NPR [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Is This 'Good News' List About the COVID-19 Pandemic Accurate? - Snopes.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- WHO expert: Finding and distributing COVID-19 vaccine in 18 months would be 'historic' - EURACTIV [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19: 5 reasons to be cautiously hopeful - Medical News Today [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Scammers are trying to trick people into reserving a COVID-19 vaccine over the phone - The Verge [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus: How scientists are racing to find a Covid-19 vaccine - ITV News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Vaccines Are Coming, but Theyre Not What You Think - The Atlantic [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- First patients injected with potential COVID-19 vaccine in ... [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 vaccine - Wikipedia [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Researchers working to fast-track a COVID-19 vaccine - FOX 9 [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Projects awarded 10.5m to boost Covid-19 vaccine research - National Health Executive [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- CureVac denies reports that Trump admin sought to acquire Covid-19 vaccine rights - MedCity News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Cork workers to be involved in race to find vaccine for Covid-19 - Echo Live [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- COVID-19 Drugs And Vaccines Showing Promise - WVXU [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall - TechCrunch [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments - WBIW.com [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Singapore scientists plan to start testing COVID-19 vaccine this year: Gan Kim Yong - CNA [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Meet the scientists contributing to race for COVID-19 vaccine - Study International News [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- The Covid-19 Vaccine: How Much Will It Cost & Who Will Have Access? - KALW [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Scientists race to find COVID-19 vaccine, as global cases of infection climb - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Soligenix Inc. Heat-Stabilization Platform Evaluating Use With COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Inovio Pharmaceuticals Gets Help From Ology Bioservices and the Defense Department with Its COVID-19 Vaccine Candidate - The Motley Fool [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- New coronavirus research suggests vaccines developed to treat it could be long-lasting - TechCrunch [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Hoth Surges on Collaboration With Voltron for COVID-19 Vaccine - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- UVM Researcher Offers Insights on Vaccines and COVID-19 - Seven Days [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- 20 Indian institutes working to find Covid-19 vaccine, IITs focused on portable ventilators - ThePrint [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Researchers in Pittsburgh, Paris and Vienna Win Grant for COVID-19 Vaccine - UPJ Athletics [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Research Team in Race to Develop COVID-19 Vaccine and Treatments - USC Viterbi School of Engineering [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]